Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2020

Combined use of galectin-3 and thyroid peroxidase improves the differential diagnosis of thyroid tumors
Authors: D. Kalfert, M. Ludvikova, I. Kholova, J. Ludvik, O. Topolcan, J. Plzak
Neoplasma Vol.67, No.1, p.164–170, 2020
doi:10.4149/neo_2019_190128N86
Price: free access
[View Abstract]


BCR/ABL preleukemic fusion gene in subpopulations of hematopoietic stem and progenitor cells from human UCB
Authors: L. Jakl, M. Skorvaga, K. Beresova, P. Kosik, M. Durdik, J. Jakubikova, M. Holop, M. Kubes, L. Zastko, E. Markova, I. Belyaev
Neoplasma Vol.67, No.1, p.158–163, 2020
doi:10.4149/neo_2019_190925N965
Price: free access
[View Abstract]


miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs)
Authors: X. Liu, X. Zhou, Y. Chen, Y. Huang, J. He, H. Luo
Neoplasma Vol.67, No.1, p.147–157, 2020
doi:10.4149/neo_2019_190511N420
Price: free access
[View Abstract]


Identification of urinary hsa_circ_0137439 as a potential biomarker and tumor regulator of bladder cancer
Authors: Z. Song, Q. Zhang, J. Zhu, G. Yin, L. Lin, C. Liang
Neoplasma Vol.67, No.1, p.137–146, 2020
doi:10.4149/neo_2018_181214N970
Price: free access
[View Abstract]


Loss of IGF2R indicates a poor prognosis and promotes cell proliferation and tumorigenesis in bladder cancer via AKT signaling pathway
Authors: S. B. Liu, L. B. Zhou, H. F. Wang, G. Li, Q. P. Xie, B. Hu
Neoplasma Vol.67, No.1, p.129–136, 2020
doi:10.4149/neo_2019_190206N108
Price: free access
[View Abstract]


Decreased expression of SorCS1 in colorectal cancer: An independent predictor of poor prognosis
Authors: P. Z. Huang, S. Y. Peng, H. C. Yu, L. Huang, Q. Yao, X. L. Wang, S. Y. Tan, J. M. Zhou, P. N. Wang, A. P. Huang, L. L. Bai, Y. X. Luo, M. J. Huang
Neoplasma Vol.67, No.1, p.119–128, 2020
doi:10.4149/neo_2019_190221N146
Price: free access
[View Abstract]


LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis
Authors: Z. Z. Liu, Y. F. Tian, H. Wu, S. Y. Ouyang, W. L. Kuang
Neoplasma Vol.67, No.1, p.111–118, 2020
doi:10.4149/neo_2019_190121N61
Price: free access
[View Abstract]


MiR-512-3p regulates malignant tumor behavior and multi-drug resistance in breast cancer cells via targeting Livin
Authors: W. J. Duan, P. D. Bi, Y. Ma, N. Q. Liu, X. Zhen
Neoplasma Vol.67, No.1, p.102–110, 2020
doi:10.4149/neo_2019_190106N18
Price: free access
[View Abstract]


MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells
Authors: Y. Zuo, W. Zheng, J. Liu, Q. Tang, S. S. Wang, X. S. Yang
Neoplasma Vol.67, No.1, p.93–101, 2020
doi:10.4149/neo_2019_190202N106
Price: free access
[View Abstract]


MiR-378a-5p inhibits angiogenesis of oral squamous cell carcinoma by targeting KLK4
Authors: Z. Cui, Q. L. Liu, S. Q. Sun, K. Jiao, D. R. Liu, X. C. Zhou, L. Huang
Neoplasma Vol.67, No.1, p.85–92, 2020
doi:10.4149/neo_2019_190306N191
Price: free access
[View Abstract]


High eukaryotic translation elongation factor 1 alpha 1 expression promotes proliferation and predicts poor prognosis in clear cell renal cell carcinoma
Authors: Y. Bao, T. L. Zhao, Z. Q. Zhang, X. L. Liang, Z. X. Wang, Y. Xiong, X. Lu, L. H. Wang
Neoplasma Vol.67, No.1, p.78–84, 2020
doi:10.4149/neo_2019_190224N158
Price: free access
[View Abstract]


Upregulated circZMIZ1 promotes the proliferation of prostate cancer cells and is a valuable marker in plasma
Authors: H. Jiang, D. J. Lv, X. L. Song, C. Wang, Y. Z. Yu, S. C. Zhao
Neoplasma Vol.67, No.1, p.68–77, 2020
doi:10.4149/neo_2019_190213N116
Price: free access
[View Abstract]


An indel polymorphism in the 3’ untranslated region of HMGB1 confers risk for hepatocellular carcinoma by regulating HMGB1 transcriptional activity in a Chinese population
Authors: J. Wang, J. Zhu, D. H. Mao, S. Zhu, X. G. Mi, Q. Yu
Neoplasma Vol.67, No.1, p.61–67, 2020
doi:10.4149/neo_2019_190221N147
Price: free access
[View Abstract]


Second-generation Src/Abl inhibitor bosutinib effectively induces apoptosis in human esophageal squamous cell carcinoma (ESCC) cells via inhibiting Src/Abl signaling
Authors: Y. N. E. Ha, Y. Dai, D. Wufuer, M. Pidayi, G. Anasihan, L. Chen
Neoplasma Vol.67, No.1, p.54–60, 2020
doi:10.4149/neo_2019_190131N94
Price: free access
[View Abstract]


HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling
Authors: X. G. CHI, X. X. MENG, D. L. DING, X. H. XUAN, Y. Z. CHEN, Q. CAI, A. WANG
Neoplasma Vol.67, No.1, p.46-53, 2020
doi:10.4149/neo_2019_190217N135
Price: free access
[View Abstract]


STIL is upregulated in nasopharyngeal carcinoma tissues and promotes nasopharyngeal carcinoma proliferation, migration and invasion
Authors: Y. Ouyang, Y. B. Jin, X. P. Chen, G. Y. Zhang, S. L. Mao, F. Ling, W. Luo
Neoplasma Vol.67, No.1, p.37-45, 2020
doi:10.4149/neo_2019_190306N192
Price: free access
[View Abstract]


Preliminary evaluation of GLP-1R PET in the diagnosis and risk stratification of pheochromocytomas
Authors: M. LI, Y. LIU, Y. XU, Y. LI, D. PAN, L. WANG, J. YAN, X. WANG, R. YANG, M. YANG
Neoplasma Vol.67, No.1, p.27-36, 2020
doi:10.4149/neo_2019_190227N163
Price: free access
[View Abstract]


PCNA and GSK3β interact with each other to regulate H1299 lung adenocarcinoma cells apoptosis
Authors: X. H. Liu, D. E. Tang, Y. Dai, X. J. Gao, L. X. Liu
Neoplasma Vol.67, No.1, p.15-26, 2020
doi:10.4149/neo_2019_190116N48
Price: free access
[View Abstract]


Understanding the crosstalk of molecular factors and signaling pathways reveals novel biomarkers of cisplatin resistance in testicular germ cell tumors
Authors: J. ROSKA, D. JURKOVICOVA
Neoplasma Vol.67, No.1, p.1-14, 2020
doi:10.4149/neo_2019_190318N244
Price: free access
[View Abstract]





Display #  
Results 141 - 159 of 159

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.